EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: PRO

Allon N Friedman iD

Kidney360 · 04.06.2026

DOI: 10.34067/kid.0000001238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 04.06.2026. Verfasst von Allon N Friedman. Beteiligte Einrichtung: Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

ORCID-Profile: Allon N Friedman

Zitieren

APA

Friedman, A. N. (2026). Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: PRO. Kidney360. https://doi.org/10.34067/kid.0000001238

Vancouver

Friedman AN. Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: PRO. Kidney360. 2026. doi:10.34067/kid.0000001238

BibTeX
@article{Friedman2026,
  author = {Friedman, Allon N},
  title = {Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: PRO},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001238}
}
Kostenlos starten →